The research about cancer patients quality of life on before and after therapy of high emetogenic cytotostatic in RSUP Dr. Sardjito Yogyakarta by EORTC QLQ_C30 has been done. This research used cohort design with cancer patients who just the first time received cisplatin ≥ 50 mg/m2 and or its combination, and alsogot ondansetron-dexamethasone as anti-emetics. While the patients were given EOR…
Every year, Dengue Hemorrhagic Fever (DHF) is the big problem Indonesian’s government with high incidency and high mortality. It would increased length of stay and high cost. The objectives of this study area to identify drug-related problems in DHF patient include need for additional drug therapy, unnecessary drug therapy, wrong drug, drug interaction, dosage to high, and dosage too low. A p…
Chemotherapy result at lung cancer patient be minimized by hematology imbalance during therarapy period. Present data show that grade 3 or 4 of hematology toxicities due to chemotherapy with regimen carboplatin + paclitaxel were rare. A cross sectional study have done to evaluhemotherapy weekly the hematology toxicities of carboplatin plus etoposide or paclitaxel as first line therapy in pat…
Chemotherapy result at lung cancer patient often be minimized by hematology imbalance during therapy period. Erythropoientin (EPO) and interleukin IL-3 were important for making red blood cell. White blood cell and platelets cell. This research was done to se whether EPO and IL-3 at lung cancer patient serum could be prediction factor for anemia caused by chemotherapy. The objective of this st…